Clinical Trial: Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Study Status: Completed
Recruit Status: Completed
Condition: Multiple Myeloma
Study Type: Interventional
Official Title: Efficacy of Response-adapted Treatment Guided by Negative Minimal Residual Disease and Negative Imaging (MRDI) in Fit Patients Diagnosed With Multiple Myeloma Who Are Candidates for Bone Marrow Transp
Brief Summary:
To assess whether continued treatment to achieve negative Minimal Residual Disease and Imaging (MRDI(-)) improves therapeutic outcomes in patients with newly diagnosed Multiple Myeloma. The primary endpoints are progression-free survival (PFS) and overall survival (OS). The safety evaluation includes the evaluation of adverse events (which are classified according to the Common Criteria for Terminology for Adverse Events of the National Cancer Institute, version 5.0).
Read more